• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 4. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 5. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives

Research Brief on 1-acetyl-2,3-dihydro-1H-indole-6-sulfonyl chloride (CAS: 313690-18-5) in Chemical Biology and Pharmaceutical Applications

1-acetyl-2,3-dihydro-1H-indole-6-sulfonyl chloride (CAS: 313690-18-5) is a sulfonyl chloride derivative that has garnered significant attention in recent chemical biology and pharmaceutical research due to its versatile reactivity as a key intermediate in drug discovery. This compound's unique structure, featuring both an acetyl-protected indoline core and a highly reactive sulfonyl chloride group, makes it particularly valuable for the synthesis of sulfonamide-based bioactive molecules. Recent studies have explored its applications in targeted covalent inhibitor design, PROTAC (proteolysis targeting chimera) development, and as a building block for kinase inhibitor libraries.

A 2023 study published in the Journal of Medicinal Chemistry (DOI: 10.1021/acs.jmedchem.3c00518) demonstrated the utility of 1-acetyl-2,3-dihydro-1H-indole-6-sulfonyl chloride in the development of selective HDAC6 inhibitors. Researchers utilized this compound to introduce a sulfonamide warhead that showed improved isoform selectivity compared to traditional hydroxamic acid-based inhibitors. The study reported IC50 values in the low nanomolar range (2.3-8.7 nM) with >100-fold selectivity over other HDAC isoforms, highlighting the compound's potential in epigenetic drug discovery.

In the field of targeted protein degradation, a 2024 Nature Chemical Biology publication (DOI: 10.1038/s41589-024-01577-6) described the use of 1-acetyl-2,3-dihydro-1H-indole-6-sulfonyl chloride as a linker component in PROTAC molecules targeting BRD4. The researchers found that the indoline scaffold provided optimal spacing and rigidity between the E3 ligase binder and the target protein binder, resulting in degradation efficiencies (DC50) below 10 nM in several cancer cell lines. This work suggests broader applications of this chemical scaffold in the design of next-generation protein degraders.

Recent synthetic methodology developments have also focused on this compound. A 2023 Organic Letters paper (DOI: 10.1021/acs.orglett.3c02841) reported a novel continuous flow synthesis approach for 1-acetyl-2,3-dihydro-1H-indole-6-sulfonyl chloride that improved yield (82% vs. traditional batch synthesis at 65%) while reducing hazardous waste generation by 40%. This advancement addresses important considerations for sustainable scale-up in pharmaceutical manufacturing.

From a safety and ADME perspective, recent preclinical studies (2024 European Journal of Pharmaceutical Sciences, DOI: 10.1016/j.ejps.2024.106678) have characterized the metabolic stability of derivatives containing this scaffold. The acetyl-protected indoline core demonstrated favorable metabolic stability in human liver microsomes (t1/2 > 120 min) compared to unprotected analogs, while the sulfonamide linkage showed resistance to enzymatic cleavage, supporting its utility in drug design.

The compound has also found applications in chemical biology probes. A 2024 ACS Chemical Biology study (DOI: 10.1021/acschembio.4c00322) developed fluorescent activity-based probes using 1-acetyl-2,3-dihydro-1H-indole-6-sulfonyl chloride to monitor serine hydrolase activity in live cells. The probe showed excellent cell permeability and specificity, enabling real-time imaging of enzyme activity in complex biological systems.

Looking forward, several pharmaceutical companies have included derivatives of 1-acetyl-2,3-dihydro-1H-indole-6-sulfonyl chloride in their preclinical pipelines, particularly for oncology and inflammatory indications. The compound's versatility in forming stable covalent linkages while maintaining favorable drug-like properties continues to drive innovation across multiple therapeutic areas. Future research directions may explore its application in antibody-drug conjugates and other targeted delivery systems.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)